NANOVIRICIDES, INC. (NNVC) Form 8-K — Jul 17, 2026
NanoViricides, Inc. entered into an At Market Issuance Sales Agreement with D. Boral Capital LLC on July 17, 2026, enabling the company to sell shares of its common stock periodically at market prices. The sales are to be made under the company's existing shelf Registration Statement on Form S-3, which was declared effective on June 15, 2026.
Key figures
- Par Value
- $0.00001
- Agent Commission
- 2.0%
- Shelf File Number
- 333-296550
- Non Affiliate Market Value
- $41,583,701
Price after filing
1 day: 0.0%7 days: -15.4%30 days: -21.1%
Close on the filing date to close N calendar days later (from $1.75). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.